Australia markets open in 1 hour 12 minutes

Supernus Pharmaceuticals, Inc. (SUPN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
28.87-0.13 (-0.45%)
At close: 04:00PM EDT
28.87 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate0.380.371.641.95
Low estimate0.290.351.531.04
High estimate0.480.41.82.55
Year ago EPS0.70.492.011.64
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate145.83M148.79M601.46M614.71M
Low estimate143.6M145M594.1M582.02M
High estimate151.9M153.07M609.84M661.7M
Year ago sales139.02M143.66M607.52M601.46M
Sales growth (year/est)4.90%3.60%-1.00%2.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS0.170.060.080.55
Actual EPS0.70.490.240.89
Difference0.530.430.160.34
Surprise %311.80%716.70%200.00%61.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.380.371.641.95
7 days ago0.380.371.641.95
30 days ago0.380.371.641.95
60 days ago0.380.431.82.15
90 days ago0.40.451.92.19
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesSUPNIndustrySector(s)S&P 500
Current qtr.-45.70%N/AN/AN/A
Next qtr.-24.50%N/AN/AN/A
Current year-18.40%N/AN/AN/A
Next year18.90%N/AN/AN/A
Next 5 years (per annum)1.69%N/AN/AN/A
Past 5 years (per annum)-17.31%N/AN/AN/A